NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024
A Contract Award Notice
by NHS ENGLAND
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- not specified
- Value
- £1
- Sector
- HEALTH
- Published
- 23 Aug 2024
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
United Kingdom: NHS England
1 buyer
- NHS England Leeds
9 suppliers
- Bayer Reading
- Teva Castleford
- Roche Products Hertfordshire
- Thornton & Ross Huddersfield
- Abbvie Maidenhead
- Biogen Idec Maidenhead
- Novartis Pharmaceuticals London
- Alimera Sciences Aldershot
- Orion Pharma Reading
Description
Project title: NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024Offer reference number CM/PHS/24/5707 Period of framework: 1 August 2024 to 31 July 2025. with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 monthsPublished By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England The Procurement relates to the supply of medical retinal vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England.
Total Quantity or Scope
Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
Award Detail
| 1 | Bayer (Reading)
|
| 2 | Teva (Castleford)
|
| 3 | Roche Products (Hertfordshire)
|
| 4 | Thornton & Ross (Huddersfield)
|
| 5 | Abbvie (Maidenhead)
|
| 6 | Biogen Idec (Maidenhead)
|
| 7 | Novartis Pharmaceuticals (London)
|
| 8 | Alimera Sciences (Aldershot)
|
| 9 | Orion Pharma (Reading)
|
Renewal Options
option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
Award Criteria
| price | _ |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Options are available.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. **
Reference
- ocds-h6vhtk-04476f
- FTS 026978-2024